ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Diabetes: Molecular Mechanisms
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1550925
This article is part of the Research TopicMolecular Pathways involved in the Pathogenesis of Diabetic Kidney DiseaseView all 3 articles
Immunological profiling in type 2 diabetes mellitus and type 2 diabetic kidney disease: insights from single-cell LacNAc sequencing
Provisionally accepted- 1School of Medicine, Qinghai University, Xining, China
- 2Department of Nephrology, Shenzhen Longhua District Central Hospital, Shenzhen, China
- 3Institute of Nephrology and Blood Purification, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Diabetic kidney disease (DKD), a major complication of type 2 diabetes mellitus (T2DM), is the leading cause of end-stage renal disease (ESRD). Recently, the innate immune system, particularly neutrophils and the process of NET formation, has garnered significant attention for its role in the progression of T2DKD in patients with T2DM. However, the underlying mechanism remains unclear.We employed single-cell LacNAc sequencing (scLacNAc-seq) to characterize immune cell populations, glycosylation patterns, and functional alterations in peripheral blood mononuclear cells (PBMCs), focusing on low-density granulocytes (LDGs), from patients with T2DM and T2DKD versus healthy controls (HC). In vitro cultures of primary human neutrophils under high glucose and high glucose plus serum from patients with T2DKD were used to assess NET formation via myeloperoxidase (MPO) detection. Plasma levels of reactive oxygen species (ROS), CXCL8, CXCR2, MPO, and neutrophil elastase (NE) were quantified by ELISA.Results: Patients with T2DM and T2DKD showed increased LDG counts and glycosylation abundance in FOLR3-and PI3-expressing subclusters. Functional enrichment analysis of overlapping differentially expressed genes (DEGs) and subclusters revealed enrichment in NET formation pathways. In vitro studies promoted NET release, as evidenced by reduced intracellular MPO and elevated supernatant MPO under hyperglycemic conditions. Plasma ROS, CXCL8, CXCR2, MPO, and NE levels were elevated in patients with T2DM and T2DKD than in HCs. Furthermore, enhanced interactions between neutrophils and mononuclear phagocytes (MPs), primarily mediated by the CXCL8/CXCR2 axis, were observed.This study identifies immunological alterations in T2DM and T2DKD, implicating neutrophil-mediated inflammation and NET formation in T2DKD progression. Correlative data suggest that targeting ROS and the CXCL8/CXCR2 pathway may represent potential therapeutic directions, though preclinical validation is warranted.
Keywords: type 2 diabetes mellitus, Diabetic kidney disease, neutrophil extracellular traps, Net formation, ROS, Oxidative Stress, single-cell LacNAc sequencing
Received: 24 Dec 2024; Accepted: 23 Jul 2025.
Copyright: © 2025 Xiao, Xu, Zhu, Chen, Wang, Wang, Gao, Luan and Pu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xiaoyan Pu, School of Medicine, Qinghai University, Xining, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.